We make unmakeable proteins with radical advanced biomanufacturing.
Future Fields has developed the world's first multicellular advanced biomanufacturing platform for the production of the most challenging recombinant proteins. We help companies in biotech, life sciences, and pharma by manufacturing their proteins.
Total raised
$21.5M
Last stage
Series A
Investors
Matt Anderson-Baron
PhD in Cell Biology from the University of Alberta. Biotech entrepreneur and co-founder of Future Fields, pioneering sustainable recombinant protein production via the EntoEngine™ platform using genetically engineered Drosophila.
LinkedInJalene Anderson-Baron
I obtained my MA from the University of Alberta and have worked in diverse analytical capacities over the past decade, focused on environmental and social causes. I'm a critical thinker with a keen attention to detail and the ability to turn big ideas into reality. I have extensive experience in health and social research, project management, stakeholder engagement, and policy planning, implementation and advocacy.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.